Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
31
BKYI Quote, Financials, Valuation and Earnings
Last price:
$0.89
Seasonality move
:
9.58%
Day range:
$0.86 - $0.99
52-week range:
$0.52 - $4.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.18x
P/B ratio:
21.15x
Volume:
150.3K
Avg. volume:
112K
1-year change:
-67.97%
Market cap:
$2.8M
Revenue:
$7.8M
EPS (TTM):
-$6.13
Analysts' Opinion
-
Consensus RatingBIO-key International has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, BIO-key International has an estimated upside of 233.33% from its current price of $0.90.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.90.
Fair Value
-
According to the consensus of 0 analysts, BIO-key International has 233.33% upside to fair value with a price target of -- per share.
BKYI vs. S&P 500
-
Over the past 5 trading days, BIO-key International has underperformed the S&P 500 by -4.94% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
BIO-key International does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
BIO-key International has grown year-over-year revenues for 1 quarter straight. In the most recent quarter BIO-key International reported revenues of $2.1M.
Earnings Growth
-
BIO-key International has grown year-over-year earnings for 0 quarters straight. In the most recent quarter BIO-key International reported earnings per share of -$0.39.
Enterprise value:
3.4M
EV / Invested capital:
1.35x
Price / LTM sales:
0.18x
EV / EBIT:
--
EV / Revenue:
0.47x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.86x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$4.3M
Return On Assets:
-89.24%
Net Income Margin (TTM):
-72.53%
Return On Equity:
-662.7%
Return On Invested Capital:
-221.43%
Operating Margin:
-27.06%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $6.2M | $7.7M | $7.3M | $1.8M | $2.1M | |
| Gross Profit | $4.4M | $2.3M | $4.3M | $340.5K | $1.7M | |
| Operating Income | -$7.1M | -$9.5M | -$5.5M | -$2M | -$580.4K | |
| EBITDA | -$6.6M | -$12.1M | -$4.8M | -$1.7M | -$540K | |
| Diluted EPS | -$16.02 | -$22.60 | -$6.13 | -$3.22 | -$0.39 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $20.4M | $16.8M | $9.9M | $7.8M | $4.6M | |
| Total Assets | $24M | $20.7M | $15M | $9.7M | $6.4M | |
| Current Liabilities | $2M | $3M | $3.3M | $6M | $5.9M | |
| Total Liabilities | $2.3M | $3.2M | $3.8M | $6.4M | $6.3M | |
| Total Equity | $21.7M | $17.5M | $11.2M | $3.3M | $133K | |
| Total Debt | $235K | -- | $441.9K | $2.7M | $2.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$6.2M | -$4.2M | -$3.9M | -$166.7K | -$1.3M | |
| Cash From Investing | -$569.8K | -$131K | -$24K | -- | -$21.2K | |
| Cash From Financing | $75.8K | $1.7M | $5.2M | -$83.1K | $1.7M | |
| Free Cash Flow | -$6.2M | -$4.2M | -$4M | -$166.7K | -$1.3M | |
BKYI
Sector
Market Cap
$2.8M
$115.4M
Price % of 52-Week High
21.85%
67.8%
Dividend Yield
0%
0%
Shareholder Yield
--
1%
1-Year Price Total Return
-67.97%
-6.36%
Beta (5-Year)
0.152
0.944
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.96
200-day SMA
Sell
Level
$1.42
Bollinger Bands (100)
Sell
Level
0.8 - 1.38
Chaikin Money Flow
Sell
Level
-328.2M
20-day SMA
Sell
Level
$1.00
Relative Strength Index (RSI14)
Sell
Level
40.27
ADX Line
Buy
Level
7.54
Williams %R
Buy
Level
-85.7143
50-day SMA
Sell
Level
$0.95
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
601.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-42.8106)
Sell
CA Score
(Annual)
Level (-5.3304)
Buy
Beneish M-Score
(Annual)
Level (-5.928)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (11.7738)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
Stock Forecast FAQ
In the current month, BKYI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BKYI average analyst price target in the past 3 months is --.
-
Where Will BIO-key International Stock Be In 1 Year?
According to analysts, the consensus estimate is that BIO-key International share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About BIO-key International?
Analysts are divided on their view about BIO-key International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that BIO-key International is a Sell and believe this share price will drop from its current level to --.
-
What Is BIO-key International's Price Target?
The price target for BIO-key International over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BKYI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for BIO-key International is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BKYI?
You can purchase shares of BIO-key International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase BIO-key International shares.
-
What Is The BIO-key International Share Price Today?
BIO-key International was last trading at $0.89 per share. This represents the most recent stock quote for BIO-key International. Yesterday, BIO-key International closed at $0.90 per share.
-
How To Buy BIO-key International Stock Online?
In order to purchase BIO-key International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
